Market Tracker

07/27 6:01pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

6.38
Delayed Data
As of 3:59pm ET
 -0.74 / -10.39%
Today’s Change
3.78
Today|||52-Week Range
11.75
+12.52%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close7.12
Today’s open6.98
Day’s range6.21 - 6.98
Volume231,604
Average volume (3 months)206,316
Market cap$167.4M
Dividend yield--
Data as of 3:59pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)+59.46%
Earnings growth (this year)+76.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.97%
P/E ratioNM
Price/Sales8,705.73
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
DPRXDipexium Pharmaceuti...-0.77-4.59%
FBIOFortress Biotech Inc-0.04-1.15%
GTXIGTX Inc+0.03+2.59%
RPRXRepros Therapeutics ...+0.14+1.95%
Data as of 3:59pm ET, 07/27/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$4.0K
Annual profit (last year)-$41.8M
Net profit margin-1,046,100.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer, Treasurer &
Senior VP
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts